Skip to main content
Skip to main content
HCARU logo

Healthcare Services Acquisition Corporation (HCARU) Stock Analysis

DELISTED 2022

What happened to Healthcare Services Acquisition Corporation (HCARU) stock?

Healthcare Services Acquisition Corporation (HCARU) no longer trades on public markets. It was delisted in December 2022. The figures below are historical and are not a current quote.

52-wk range: $9.79 – $10.10
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Healthcare Services Acquisition Corporation (HCARU) trades at $10.10. Healthcare Services Acquisition Corporation is a shell company focused on mergers, acquisitions, and reorganizations within the healthcare sector. Currently, the company does not have significant operational activities. Sector: Financial services.

Last analyzed: Mar 16, 2026
Healthcare Services Acquisition Corporation is a shell company focused on mergers, acquisitions, and reorganizations within the healthcare sector. Currently, the company does not have significant operational activities.

Analyst Coverage for HCARU: HCARU does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates HCARU against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the HCARU film Every key number, told as a short cinematic story — just press play. ~2 min

Healthcare Services Acquisition Corporation (HCARU) Financial Services Profile

CEODavid T. Blair
HeadquartersBethesda, US
IPO Year2020

Healthcare Services Acquisition Corporation, a shell company incorporated in 2020, is strategically positioned to pursue a merger, acquisition, or reorganization within the healthcare industry. The company is based in Bethesda, Maryland, and currently maintains no significant operational activities as it seeks a suitable business combination.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 16, 2026

What Is the Investment Thesis for HCARU?

As of Mar 16, 2026 — figures reflect the data available on that date.

The investment thesis for Healthcare Services Acquisition Corporation hinges on its ability to identify and successfully merge with a promising healthcare company. As a SPAC, HCARU offers investors exposure to potential high-growth opportunities within the healthcare sector without the direct operational risks. Key value drivers include the management team's expertise in healthcare and deal-making, the attractiveness of the target company, and the overall market conditions for mergers and acquisitions. The current P/E ratio is 3.30. However, potential risks include the failure to find a suitable target, unfavorable deal terms, and regulatory hurdles. The timeline for realizing value is dependent on the successful completion of a merger or acquisition, typically within 24 months of the IPO.

Based on FMP financials and quantitative analysis

HCARU Key Highlights

Healthcare Services Acquisition Corporation operates as a shell company, focusing on mergers and acquisitions within the healthcare sector.

  • The company was incorporated in 2020 and is based in Bethesda, Maryland.
  • HCARU's primary objective is to effect a business combination with one or more businesses in the healthcare industry.
  • The company currently has no significant operations, existing solely to identify and acquire a target company.
  • The P/E ratio is 3.30, reflecting market expectations regarding a potential acquisition.

Who Are HCARU's Competitors?

HCARU is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
AGGI Allied Energy, Inc. $2.25 +32.24% $45.4B 61
GSHN Gushen, Inc. $22.70 +2.71% $9.32B 61
IVAN Ivanhoe Capital Acquisition Corp. $7.68 -2.17% $2.69B 64
APXTW Apex Treasury Corporation $0.35 -5.41% $1.89B 66
APXT Apex Technology Acquisition Corp. $10.12 -0.05% $1.89B 64
APXTU Apex Treasury Corporation $10.26 +0.39% $1.89B 64
WCHS Winchester Holding Group $5.01 +0.00% $532M 63
MESH Meshflow Acquisition Corp. $10.04 -0.05% $433M 64

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are HCARU's Key Strengths?

Experienced management team with healthcare expertise

  • Access to capital through IPO
  • Focus on the high-growth healthcare sector

What Are HCARU's Weaknesses?

No current operations or revenue

  • Dependence on finding a suitable acquisition target
  • Competition from other SPACs

What Could Drive HCARU Stock Higher?

Announcement of a definitive agreement to acquire a target company.

  • Progress in negotiations with potential acquisition targets.
  • Positive developments in the healthcare sector that increase the attractiveness of potential targets.

What Are the Key Risks for HCARU?

Failure to find a suitable acquisition target within the specified timeframe.

  • Unfavorable deal terms that reduce shareholder value.
  • Regulatory hurdles that delay or prevent the completion of a merger.
  • Increased competition from other SPACs driving up acquisition prices.
  • Market volatility impacting the valuation of potential target companies.

What Are the Growth Opportunities for HCARU?

  • Successful Acquisition of a High-Growth Healthcare Company: HCARU's primary growth opportunity lies in identifying and acquiring a high-growth healthcare company with strong fundamentals and a clear path to profitability. The target company could be in areas such as biotechnology, medical devices, healthcare IT, or specialized healthcare services. The timeline for this growth opportunity is dependent on the successful completion of a merger or acquisition, typically within 24 months of the IPO. A well-chosen target could significantly increase shareholder value.
  • Strategic Partnerships and Alliances: HCARU can explore strategic partnerships and alliances with other healthcare companies or investment firms to enhance its deal-sourcing capabilities and access to capital. These partnerships could provide access to a broader network of potential target companies and increase the likelihood of finding a suitable acquisition. The timeline for establishing these partnerships is relatively short, potentially within the next 6-12 months. Successful partnerships could lead to more attractive acquisition opportunities and improved deal terms.
  • Expansion into Adjacent Healthcare Sectors: While HCARU's initial focus is on the broader healthcare sector, it could explore expansion into adjacent sectors such as wellness, preventative care, or healthcare technology. These sectors offer significant growth potential and could provide diversification benefits. The market size for these adjacent sectors is substantial and growing rapidly. The timeline for this expansion is longer-term, potentially 2-3 years after completing an initial acquisition. Diversification could reduce risk and enhance long-term growth prospects.
  • Leveraging Management Expertise and Network: HCARU's management team has expertise in healthcare and deal-making, which can be leveraged to identify and evaluate potential acquisition targets. The management team's network of contacts within the healthcare industry can provide access to proprietary deal flow and insights into emerging trends. The timeline for leveraging this expertise is ongoing, as the management team actively seeks and evaluates potential acquisition targets. A strong management team is a key competitive advantage in the SPAC market.
  • Capitalizing on Market Consolidation Trends: The healthcare industry is undergoing significant consolidation, with larger companies acquiring smaller players to gain market share and expand their capabilities. HCARU can capitalize on this trend by targeting companies that are attractive acquisition targets for larger players. The timeline for this opportunity is medium-term, potentially 1-2 years after completing an initial acquisition. A successful acquisition could position HCARU as a valuable asset in a consolidating market.

What Are HCARU's Competitive Advantages?

  • Management Team Expertise: The management team's experience in healthcare and deal-making provides a competitive advantage.
  • Access to Capital: HCARU's IPO provides access to a significant amount of capital for acquisitions.
  • Focus on Healthcare: Specializing in the healthcare sector allows for targeted deal sourcing and industry expertise.

What Does HCARU Do?

Healthcare Services Acquisition Corporation (HCARU) was founded in 2020 and is based in Bethesda, Maryland. As a special purpose acquisition company (SPAC), HCARU's primary objective is to identify and complete a business combination with one or more operating businesses through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar transaction. The company does not have significant operations of its own. Instead, it exists as a vehicle to raise capital through an initial public offering (IPO) and then use those funds to acquire or merge with a private company, effectively taking the target company public. HCARU focuses specifically on targets within the healthcare sector, aiming to leverage opportunities in a rapidly evolving industry. The success of HCARU depends on its ability to find a suitable target, negotiate favorable terms, and complete the transaction, ultimately delivering value to its shareholders.

What Products and Services Does HCARU Offer?

  • Healthcare Services Acquisition Corporation is a special purpose acquisition company (SPAC).
  • It focuses on identifying and acquiring a company in the healthcare industry.
  • The company aims to complete a merger, capital stock exchange, or asset acquisition.
  • HCARU seeks to take a private healthcare company public through a reverse merger.
  • It provides a vehicle for investors to participate in potential healthcare growth opportunities.
  • The company's success depends on finding a suitable target and completing the acquisition.

How Does HCARU Make Money?

  • HCARU raises capital through an initial public offering (IPO).
  • It uses the IPO proceeds to fund the acquisition of a target company.
  • The company generates returns for investors through the appreciation of the target company's stock price after the merger.

What Industry Does HCARU Operate In?

Healthcare Services Acquisition Corporation operates within the shell company industry, specifically targeting the healthcare sector. The SPAC market has seen significant growth in recent years, driven by the desire of private companies to go public more quickly and with less regulatory scrutiny than traditional IPOs. The competitive landscape includes numerous other SPACs, each vying to identify and acquire attractive targets. The healthcare industry is particularly appealing due to its high growth potential, driven by factors such as an aging population, technological advancements, and increasing healthcare spending. However, the SPAC market is also subject to volatility and regulatory changes, which can impact the success of these ventures.

Who Are HCARU's Key Customers?

  • HCARU's customers are investors who participate in its IPO.
  • These investors seek exposure to the healthcare sector through a SPAC vehicle.
  • The company also serves the target company it acquires by providing access to public markets and capital.
AI Confidence: 66% Updated: Mar 16, 2026

Company Profile

Healthcare Services Acquisition Corporation operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Bethesda, US. The company is led by CEO David T. Blair. HCARU has traded publicly since 2020.

ROE 8%

Key Financial Metrics

Return on equity for Healthcare Services Acquisition Corporation stands at 8.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 7.6%, showing how much profit it generates from its asset base. HCARU trades at a trailing price-to-earnings ratio of 3.30, below the Financial Services sector average of ~18x. A current ratio of 4.19 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 30.3%, the inverse of the P/E and a quick read on earnings relative to price.

HCARU Financials

Bull Case vs Bear Case

Bull Case

  • Experienced management team with healthcare expertise
  • Access to capital through IPO
  • Focus on the high-growth healthcare sector
  • Upcoming: Announcement of a definitive agreement to acquire a target company.

Bear Case

  • No current operations or revenue
  • Dependence on finding a suitable acquisition target
  • Competition from other SPACs
  • Potential: Failure to find a suitable acquisition target within the specified timeframe.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

HCARU Latest News

No recent news available for HCARU.

Leadership: David T. Blair

CEO

David T. Blair serves as the CEO of Healthcare Services Acquisition Corporation. His background includes extensive experience in the healthcare industry, with a focus on healthcare services and technology. Blair has held leadership positions in various healthcare organizations, demonstrating his expertise in strategic planning, operations management, and business development. His experience also includes involvement in healthcare policy and advocacy, reflecting a deep understanding of the healthcare landscape. Blair's qualifications and experience position him to lead HCARU in identifying and acquiring a promising healthcare company.

Track Record: Under David T. Blair's leadership, Healthcare Services Acquisition Corporation is actively pursuing potential acquisition targets within the healthcare sector. His strategic focus is on identifying companies with strong growth potential and innovative solutions. Blair's track record includes successfully navigating complex transactions and building strong relationships with industry stakeholders. His leadership is crucial in guiding HCARU towards a successful merger or acquisition.

What Investors Ask About Healthcare Services Acquisition Corporation (HCARU) — Financial Services

What happened to Healthcare Services Acquisition Corporation (HCARU) stock?

Healthcare Services Acquisition Corporation (HCARU) no longer trades on public markets. It was delisted in December 2022. The figures below are historical and are not a current quote.

Can I still buy HCARU shares?

No. HCARU stopped trading on public markets in December 2022, so the shares are not available through a broker. Anything you see quoted for HCARU elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before HCARU stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Healthcare Services Acquisition Corporation. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

What does Healthcare Services Acquisition Corporation do?

Healthcare Services Acquisition Corporation is a special purpose acquisition company (SPAC) focused on merging with or acquiring a company in the healthcare industry. As a shell company, its primary function is to raise capital through an initial public offering (IPO) and then use those funds to identify and acquire a private healthcare business, effectively taking it public.

What do analysts say about HCARU stock?

As a special purpose acquisition company (SPAC), Healthcare Services Acquisition Corporation's stock performance is primarily driven by speculation regarding its potential acquisition target and the terms of the deal. The P/E ratio is 3.30. Analysts typically focus on the management team's expertise, the attractiveness of the healthcare sector, and the overall market conditions for mergers and acquisitions.

What are the main risks for HCARU?

The primary risks for Healthcare Services Acquisition Corporation include the failure to find a suitable acquisition target within the specified timeframe, which could lead to the liquidation of the company and the return of capital to shareholders.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • AI analysis is pending, which may provide additional insights.
  • The information provided is based on publicly available data and may be subject to change.
Data Sources

Popular Stocks

More Stocks We Cover